4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-049421
Chief Executive Officer gave up 779 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Kulkarni Samarth · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-02 | Shares withheld for taxes : show line 1 in the form | −779 | $94.15 | $73,343 | 169,968 | D |
Loading xslF345X03/doc4.xml…